Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry
Shane Hanon, Guy Brusselle, Maud Deschampheleire, et al.
European Respiratory Journal (2020) Vol. 56, Iss. 6, pp. 2002857-2002857
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

GEMA 5.3. Spanish Guideline on the Management of Asthma
Vicente Plaza, Isam Alobid, Cesáreo Álvarez Rodríguez, et al.
Open Respiratory Archives (2023) Vol. 5, Iss. 4, pp. 100277-100277
Open Access | Times Cited: 62
Asthma and COVID-19: an update
Yochai Adir, Walid Saliba, Antoine Beurnier, et al.
European Respiratory Review (2021) Vol. 30, Iss. 162, pp. 210152-210152
Open Access | Times Cited: 89
COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: Nationwide real-world evidence
Yochai Adir, Marc Humbert, Walid Saliba
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 2, pp. 361-367.e13
Open Access | Times Cited: 74
Eosinophils and COVID-19: diagnosis, prognosis, and vaccination strategies
Helene F. Rosenberg, Paul S. Foster
Seminars in Immunopathology (2021) Vol. 43, Iss. 3, pp. 383-392
Open Access | Times Cited: 55
Asthma and COVID-19: a dangerous liaison?
Carlo Lombardi, Federica Gani, Alvise Berti, et al.
Asthma Research and Practice (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 46
Emerging Paradigms in Type 2 Immunity
Hamida Hammad, Nincy Debeuf, Helena Aegerter, et al.
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 443-467
Open Access | Times Cited: 29
Epidemiology, Healthcare Resource Utilization, and Mortality of Asthma and COPD in COVID-19: A Systematic Literature Review and Meta-Analyses
David Halpin, Adrian Paul J. Rabe, Wei Jie Loke, et al.
Journal of Asthma and Allergy (2022) Vol. Volume 15, pp. 811-825
Open Access | Times Cited: 29
Asthma and COVID-19: do we finally have answers?
Katrien Eger, Elisabeth H. Bel
European Respiratory Journal (2020) Vol. 57, Iss. 3, pp. 2004451-2004451
Open Access | Times Cited: 42
The effect of allergy and asthma as a comorbidity on the susceptibility and outcomes of COVID-19
Yadong Gao, Ioana Agache, Mübeccel Akdiş, et al.
International Immunology (2021) Vol. 34, Iss. 4, pp. 177-188
Open Access | Times Cited: 39
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group
Francesca Ferretti, Rosanna Cannatelli, Maurizio Benucci, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 37
Anti-IL5 Drugs in COVID-19 Patients: Role of Eosinophils in SARS-CoV-2-Induced Immunopathology
Daniele Pala, Marco Pistis
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 36
Emerging Evidence for Pleiotropism of Eosinophils
José M. Rodrigo‐Muñoz, Marta Gil‐Martínez, Beatriz Sastre, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7075-7075
Open Access | Times Cited: 32
Implications of preexisting asthma on COVID-19 pathogenesis
Rakhee K. Ramakrishnan, Saba Al Heialy, Qutayba Hamid
AJP Lung Cellular and Molecular Physiology (2021) Vol. 320, Iss. 5, pp. L880-L891
Open Access | Times Cited: 30
SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics
Andriana Ι. Papaioannou, Evangelia Fouka, Νikolaos Tzanakis, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 10, pp. 2588-2595
Open Access | Times Cited: 17
Impact of the COVID-19 pandemic on the management of chronic noninfectious respiratory diseases
Angélica Tiotiu, Herberto Chong Neto, András Bikov, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 8, pp. 1035-1048
Closed Access | Times Cited: 23
Recent advances in understanding the role of eosinophils
Gregory Constantine, Amy D. Klion
Faculty Reviews (2022) Vol. 11
Open Access | Times Cited: 14
Omalizumab may protect allergic patients against COVID-19: A systematic review
Daniele Giovanni Ghiglioni, Laura Cozzi, Riccardo Castagnoli, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 2, pp. 100741-100741
Open Access | Times Cited: 8
Adult Severe Asthma Registries: A Global and Growing Inventory
Breda Cushen, Mariko Siyue Koh, Trung N. Tran, et al.
Pragmatic and Observational Research (2023) Vol. Volume 14, pp. 127-147
Open Access | Times Cited: 8
Facts and Challenges about Asthma and COVID-19 among the Paediatric Population: A Systematic Literature Review
Emilia Moreno Sánchez, Estefanía Castillo Viera, Emilia Vélez-Moreno, et al.
Medicina (2021) Vol. 57, Iss. 12, pp. 1306-1306
Open Access | Times Cited: 20
Lung epithelial cells: Upstream targets in type 2‐high asthma
Sahine Lameire, Hamida Hammad
European Journal of Immunology (2023) Vol. 53, Iss. 11
Open Access | Times Cited: 7
Novel therapeutic approaches targeting endotypes of severe airway disease
Maria De Filippo, Martina Votto, Amelia Licari, et al.
Expert Review of Respiratory Medicine (2021) Vol. 15, Iss. 10, pp. 1303-1316
Closed Access | Times Cited: 17
COVID-19 Clinical Features and Outcome in Italian Patients Treated with Biological Drugs Targeting Type 2 Inflammation
Giada Sambugaro, Elena Brambilla, Giulia Costanzo, et al.
Life (2024) Vol. 14, Iss. 3, pp. 378-378
Open Access | Times Cited: 2
Roles of real-world evidence in severe asthma treatment: challenges and opportunities
Young‐Soo Lee, Ji‐Hyang Lee, So Young Park, et al.
ERJ Open Research (2022) Vol. 9, Iss. 2, pp. 00248-2022
Open Access | Times Cited: 10
Incidence of COVID-19 in Patients With Chronic Idiopathic Urticaria and Asthma on Omalizumab: A Multicentre Retrospective Cohort Study
Abrahim Abduelmula, Jorge R. Georgakopoulos, Asfandyar Mufti, et al.
Journal of Cutaneous Medicine and Surgery (2021) Vol. 26, Iss. 3, pp. 319-320
Open Access | Times Cited: 14
Severe asthma in the era of COVID-19: A narrative review
João Gaspar Marques, Mafalda van Zeller, Pedro Martins, et al.
Pulmonology (2021) Vol. 28, Iss. 1, pp. 34-43
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top